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Introduction
Adrenal incidentalomas are encountered frequently as a
result of the application of high-resolution anatomical
imaging procedures. About 85% of incidentally found
adrenal masses are nonfunctional masses, 9% are defined
as subclinical Cushing’s syndrome (SCS), 4% are pheo-
chromocytomas, and only 1% of them are aldosterono-
mas.1 Simultaneous occurrence of adrenocortical tumor
and pheochromocytoma is rarely seen in the same gland.
Herein, we report an extremely rare case of adrenal
incidentaloma consisting of both medullary and cortical
tumors in the same gland.
Case Report
A 51-year-old female patient had had diabetes and
hypertension for more than 10 years. Her high blood
pressure was not paroxysmal type, and she had never
experienced sudden episodes of headache, palpitation,
profuse sweating or hot flushes. Her mean plasma glu-
cose was around 300 mg/dL and blood pressure was
160/80 mmHg or so despite taking antidiabetic agents
combined with insulin and antihypertension drugs
regularly. This patient had gained about 11 kg body
weight in the past 1 month. She had been followed
up at the neurology clinic for diabetic neuropathy.
Abdominal computed tomography (CT) for possible
pancreatic lesion was arranged by the neurologist, and
incidentally revealed a heterogeneous attenuation tumor
with fat component, 4.2 × 3.4 × 3 cm in size, in the
right adrenal gland (Figure 1A). Then, the patient
was referred to the endocrine clinic for further evalua-
tion. The urine free cortisol (UFC) was 79.8 µg/day
(normal, < 100 µg/day), and morning plasma cortisol
and adrenocorticotropic hormone (ACTH) concentra-
tions were 20.43 µg/dL (normal, 5–25 µg/dL) and
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A right adrenal tumor was found incidentally during abdominal computed tomography exam in a 51-year-old female
patient, who had had diabetes and hypertension for more than 10 years. The computed tomography scan was arranged
for possible pancreatic lesion by a neurologist. Norepinephrine level was high in the plasma and urine. Vanillylmandelic
acid level was elevated in the urine. Diurnal cortisol rhythm, plasma adrenocorticotropic hormone and urine free cortisol
were all normal, but the plasma cortisol concentration could not be suppressed after a standard low-dose dexametha-
sone suppression test. Therefore, adrenal cortical adenoma with subclinical Cushing’s syndrome was highly suspected;
however, further imaging studies, including magnetic resonance image and 131I-6β-iodomethylnorcholesterol adrenal
scintigraphy failed to discriminate an additional tumor. After right adrenalectomy, a small adrenal cortical adenoma and a
large pheochromocytoma were noted. This is an extremely rare case of an adrenal incidentaloma consisting of both
medullary and cortical tumors in the same gland. [J Chin Med Assoc 2007;70(7):289–293]
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20.5pg/mL (normal, 9–52pg/mL), respectively. How-
ever, urine norepinephrine level was markedly elevated
to 431 µg/day (normal, 10–80 µg/day). Therefore,
the patient was admitted to our hospital for further
examination and treatment.
On admission, physical examination revealed a gen-
eralized obese women, 168 cm in height and 90 kg 
in weight. There were no classic signs of Cushing’s
syndrome such as purple striae, facial plethora, buf-
falo hump, and ecchymoses. Blood pressure was 160/
80 mmHg, and pulse rate was 80/min. Laboratory
examinations revealed her condition as follows: fast-
ing plasma glucose 410 mg/dL, glycated hemoglobin
12.1%; serum sodium 132 mmol/L (normal, 135–
147 mmol/L), potassium 4.6 mmol/L (normal, 3.4–
4.7 mmol/L); total cholesterol 470 mg/dL (normal,
125–240mg/dL), triglycerides 1,624mg/dL (normal,
20–200 mg/dL), and recumbent plasma aldoste-
rone 105 pg/mL (normal, 10–160 pg/mL). Urinary
excretion of vanillylmandelic acid and both plasma
and urine norepinephrine concentrations were high
(Table 1). A 24-hour UFC excretion and circadian
rhythms of plasma cortisol and ACTH were normal.
The plasma cortisol levels could only be suppressed
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Figure 1. (A) Contrast-enhanced computed tomography reveals a heterogeneous mass (arrow) in the right adrenal gland. (B) Magnetic
resonance imaging shows the high signal intensity of the mass on T2-weighted imaging. (C) Chemical shift in-phase and (D) opposed-
phase disclose no obvious signal intensity decrease of the tumor.
Table 1. Endocrinologic studies for pheochromocytoma
In this patient Reference range
Plasma
Epinephrine (pg/mL) 26 10–67
Norepinephrine (pg/mL) > 2,000 950–446
Urine
Epinephrine (µg/d) 8 0–24
Norepinephrine (µg/d) 226 10–80
Dopamine (µg/d) 116 138–540
Vanillylmandelic acid 11.3 1.0–7.0
(mg/d)
by a standard high-dose dexamethasone suppression
test with dexamethasone 2.0 mg po q6h for 2 days
rather than by a standard low-dose dexamethasone
suppression test with 0.5mg dexamethasone po q6h for
2 days (Table 2).
The 131I-6β-iodomethylnorcholesterol (NP-59)
adrenal scintigraphy, after giving dexamethasone sup-
pression (8 mg/day), failed to show any adrenal uptake
within 5 days. Abdominal magnetic resonance image
(MRI) revealed high signal intensity on a T2-weighted
image and no obvious chemical shift of the right adrenal
mass (Figures 1B–D).
Right adrenalectomy was performed, and 2 tumors
were found in the same gland. The sizes of the tumors
were 6.0 × 4.0 × 1.5 cm and 1.5 × 1.0 × 1.0 cm, respec-
tively (Figure 2A). Histologically, the small tumor,
yellowish, encapsulated and composed of lipid-laden
clear cells, was diagnosed an adrenal cortical adenoma
(Figures 2B, 2C). The large brownish tumor was a
pheochromocytoma composed of large cells with abun-
dant basophilic granular cytoplasm and mildly nuclear
pleomorphism (Figure 2D).
The results of endocrinologic tests, including ACTH
stimulation test, were all normal after the operation.
However, glycemic control remained poor and the
patient’s weight remained the same 1 year later.
Discussion
The simultaneous occurrence of pheochromocytoma
and adrenal cortical adenoma is extremely rare, espe-
cially in the same adrenal gland. There have only been
13 pheochromocytomas either with functioning or
non-functioning adrenal cortical adenoma reported,
more than half of which were found in Japan.2–13 The
coexistence was believed to be coincidental in most
reports. Catecholamines have an effect on steroidoge-
nesis of adjacent cortical cells by a paracrine manner.14
Human pheochromocytoma may also synthesize and
secrete several regulatory peptides, such as adreno-
medullin, somatostatin, neuropeptide Y, and galanin,
which are able to influence adrenocortical steroid pro-
duction.14 In addition, adrenal medulla may serve as
an extrapituitary source of ACTH production. Long-
term secretion of ACTH, catecholamines and several
other peptides might result in adrenal cortical ade-
noma formation. However, it is still difficult to explain
why most patients with pheochromocytoma do not
develop cortical hyperplasia or adenomas.
In the present case, although there were no typical
symptoms and signs, a large pheochromocytoma was
diagnosed without difficulty according to the bio-
chemical data and imaging studies. Larger pheochro-
mocytomas may outgrow the corticomedullary blood
supply, thus losing the exposure to high local concen-
trations of glucocorticoids that regulate the activity 
of phenylethanolamine-N-methyltransferase (PNMT),
which is an essential enzyme to convert norepine-
phrine into epinephrine in the adrenal gland.15 This
may explain the disproportionately high plasma and
urine concentration of norepinephrine to epinephrine
in this case.
The patient had a normal 24-hour UFC level 
and normal circadian rhythms of plasma cortisol and
ACTH. However, abnormal low-dose dexametha-
sone suppression test made SCS a reasonable suspicion,
although the abdominal MRI and NP-59 adrenal
scintigraphy failed to discriminate an adrenal cortical
tumor. Corticotropin-releasing hormone stimulation
test may provide more information in this case,16
however, it was not taken at that time.
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Table 2. Endocrinologic studies for Cushing’s syndrome
Day 1 Day 2 Reference range
Baseline
8 AM serum cortisol (µg/dL) 12.12 21.14 5–25
10 PM serum cortisol (µg/dL) 2.70 6.66 < 5
8 AM plasma ACTH (pg/mL) 10.0 10.0 9–52
10 PM plasma ACTH (pg/mL) 4.0 5.0 9–52
UFC (µg/d) 7.9 2.9 < 100
LDDST
8 AM serum cortisol (µg/dL) 5.58 < 1.85
HDDST
8 AM serum cortisol (µg/dL) 0.55
ACTH = adrenocorticotropic hormone; UFC = urine free cortisol; LDDST = low-dose dexamethasone suppression test; HDDST = high-dose dexamethasone 
suppression test.
NP-59 scintigraphy is a sensitive functional adrenal
imaging study, but it still failed to detect the adreno-
cortical adenoma in this case. There might be 3 possi-
bilities for why. One is the hypercholesterolemia of the
patient, which would disturb uptake of NP-59, leading
to non-visualization of the adrenal glands. The others
are that the cortical adenoma might have been too
small to be detected and the tumor may have had low
autonomous function which could be suppressed by
high-dose dexamethasone during NP-59 scintigraphy.
In conclusion, adrenal incidentaloma usually exists as
a nonfunctional or a single hormone-producing tumor.
But there is a possibility that both adrenal medulla
and cortical tumors might occur in the same gland.
Thus, complete adrenal functional studies in adrenal
incidentalomas are strongly suggested before surgical
intervention to prevent intraoperative hypertensive
crisis or postoperative adrenal insufficiency.
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